Entera Bio (ENTX) Expected to Announce Quarterly Earnings on Friday

Entera Bio (NASDAQ:ENTX - Get Free Report) is expected to issue its quarterly earnings data before the market opens on Friday, March 14th. Analysts expect the company to announce earnings of ($0.08) per share and revenue of $0.04 million for the quarter.

Entera Bio Stock Down 5.8 %

NASDAQ:ENTX traded down $0.11 during trading hours on Monday, reaching $1.78. The company had a trading volume of 78,995 shares, compared to its average volume of 143,826. The stock has a 50-day moving average of $2.28 and a two-hundred day moving average of $2.01. Entera Bio has a one year low of $1.30 and a one year high of $3.35. The firm has a market capitalization of $63.70 million, a PE ratio of -6.85 and a beta of 1.62.

Analyst Upgrades and Downgrades

Separately, HC Wainwright reissued a "buy" rating and issued a $10.00 price target on shares of Entera Bio in a report on Monday, November 11th.

Entera Bio Company Profile

Entera Bio Ltd., a clinical-stage company, focuses on the development and commercialization of orally delivered peptide and protein therapeutics for unmet medical needs. The company's product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials for the treatment of stress fractures.